— CATEGORY · 3 COMPOUNDS

Oxidative pathway research compounds

Oxidative pathway research peptides and reagents studied in preclinical models for their roles in cellular antioxidant defence, collagen and elastin synthesis, and the sirtuin enzyme pathway.

This category includes GHK-Cu, a naturally occurring copper tripeptide extensively researched in dermatological cellular models; L-Glutathione (Reduced), the foundational intracellular antioxidant involved in mitochondrial redox balance; and Melanotan II, a synthetic alpha-MSH analogue binding across multiple melanocortin receptor subtypes.

For in vitro research use only. Compounds in this category are not for human or veterinary consumption, diagnosis, treatment, cure, or prevention of any condition.

Compounds in oxidative pathway research

Research bundles containing oxidative pathway research compounds

Explore all curated multi-compound bundles View all 10 research bundles →

Frequently asked — oxidative pathway research

What compounds does Velox Peptides supply for oxidative pathway research?
Velox Peptides supplies 3 research compounds in this category: GHK-Cu, Glutathione, Melanotan II. All are HPLC-verified by a third-party laboratory.
Are these peptides for human use?
No. All compounds supplied by Velox Peptides are strictly for in vitro research use by qualified researchers. They are not medicinal products and are not for human or veterinary consumption.
How are research peptides supplied?
Research compounds are supplied as lyophilised (freeze-dried) powders in sterile vials for reconstitution with bacteriostatic water prior to research use. See our reconstitution calculator for concentration and volume calculations.
Is purity documentation available?
Yes. Batch documentation is available on request. Previous batch CoAs are available in our CoA library.
Compliance statement. Velox Peptides supplies research reagents for in vitro use by qualified researchers. Every compound is sold strictly as a research reagent. No product is a medicinal product within the meaning of the Human Medicines Regulations 2012. No product has been evaluated by the MHRA or FDA. No product is intended for human or veterinary consumption, diagnosis, treatment, cure, or prevention of any condition. Any use outside lawful scientific research is outside the scope of sale. See our Research Use Policy and MHRA Statement.